Welchol Lowers A1C In Diabetes Patients
Data from Daiichi Sankyo’s post-hoc analyses of three pivotal studies demonstrated that the addition of Welchol, (colesevelam HCl) to common diabetes treatment regimens can lower A1C in patients with type 2 diabetes mellitus by 1% or greater. Read more
Mediterranean Diet Protects Against Diabetes
The traditional Mediterranean diet provides substantial protection against type 2 diabetes, according to a study published on bmj.com today and titeled Adherence to Mediterranean diet and risk of developing diabetes: prospective cohort study. Read more
Pine Bark Reduces Cardiovascular Risk In Diabetics
Pycnogenol (pic-noj-en-all), an antioxidant plant extract from the bark of the French maritime pine tree, reduces blood sugar in type II diabetes patients, allows people to lower their antihypertensive medication and improves cardiovascular disease (CVD) risk factors. Read more
Bone Cells Influence Blood Stem Cell Replication, Migration
Using a novel investigatory technique, researchers at the Joslin Diabetes Center have established that osteoblasts, cells responsible for bone formation, are also directly involved in the proliferation and expansion of blood-forming hematopoietic stem cells. Read more
Understanding Diabetes
To manage diabetes, it helps to understand how it affects your body. In healthy people, the body turns food into glucose (blood sugar) to use for energy. Insulin, produced by the pancreas, is the hormone responsible for shuttling glucose into the body’s cells where it is either used right away or stored for later use. Read more
Erectile Dysfunction Predicts Coronary Heart Disease in Type 2 Diabetes
The current issue of the Journal of the American College of Cardiology has two interesting studies in the relationship of Erectile Dysfunction and Coronary Heart Disease in men with Type 2 Diabetes. Read more
Naturlose Readily Accepted By Diabetes Patients
Naturlose, a natural sugar approved as a food ingredient in US and abroad, has been found to reduce the spikes of serum glucose that follow consumption of food. In a Phase 3 human clinical trial, Spherix is currently studying the efficacy and safety of Naturlose for the treatment of diabetes. Read more